CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Santen Pharmaceutical Co., Ltd. v. Sandoz Inc.

1:16-cv-00354

Overview

Case Number 1:16-cv-00354
Filing Date 2016-05-13
Status Terminated
Termination Date 2017-08-28
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Sandoz Inc. Operating Company

Represented By

2 Attorneys Listed

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

1200 North Broom St., Wilmington, DE 19806

John C. Phillips , Jr.

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

1200 North Broom St., Wilmington, DE 19806, Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St, Wilmington, DE 19806

Plaintiff

Asahi Glass Co., Ltd. Operating Company

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

1201 North Market St., P.O. Box 1347, Wilmington, DE 19899

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

1201 North Market St., P.O. Box 1347, Wilmington, DE 19899

Oak Pharmaceuticals, Inc. Operating Company

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

1201 North Market St., P.O. Box 1347, Wilmington, DE 19899

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

1201 North Market St., P.O. Box 1347, Wilmington, DE 19899

Santen Pharmaceutical Co., Ltd. Operating Company

Represented By

6 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

1201 North Market St., P.O. Box 1347, Wilmington, DE 19899

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

1201 North Market St., P.O. Box 1347, Wilmington, DE 19899

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): 🇯🇵 Japan 🇺🇸 US
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 1 U.S. Courts: 1
USPTO PTAB Trial 2017-05-12
IPR2017-01434

Micro Labs Limited et al. v. Santen Pharmaceutical Co., Ltd. et al.

Asserted Patent
Status: Final Written Decision
U.S. District Court 2016-05-13
1:16-cv-00353

Santen Pharmaceutical Co., Ltd. v. Micro Labs Limited

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5886035
Difluoroprostaglandin derivatives and their use
Filed: 1997-12-18
Issued: 1999-03-23
Expired (Term Ended) +1826d PTA
Expires: 2022-12-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1826 days) / Cellect Scrutiny — Over 1826 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 2 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending
ORAL ORDER re (14 in 1:16-cv-00354-GMS, 18 in 1:16-cv-00353-GMS) Joint Status Report - The parties' proposed schedule is ADOPTED, with the following additions: ...
Entry #— • 2016-10-11
Procedural / Extension Motion Pending
SO ORDERED - re 10 STIPULATION TO EXTEND TIME time for Defendant to answer, move or otherwise respond to Plaintiffs' Complaint to July 22, 2016 filed by Sandoz ...
Entry #— • 2016-06-08
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME time for Defendant to answer, move or otherwise respond to Plaintiffs' Complaint to July 22, 2016 - filed by Sandoz Inc.. (Phillips, ...
Entry #10 • 2016-06-07 Document →

Docket Entries

(55 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGMENT filed against Sandoz Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1931013.) - filed by Santen Pharmaceutical Co., Ltd., Asahi Glass Co., Ltd., Oak Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Attachment 2 replaced on 5/16/2016) (sec). (Entered: 05/13/2016)

Entry #1 • 2016-05-13
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 05/13/2016)

Entry #2 • 2016-05-13
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/7/2016. Date of Expiration of Patent: 12/18/2022.Thirty Month Stay Deadline: 8/10/2019. (nmb) (Entered: 05/13/2016)

Entry #3 • 2016-05-13
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,886,035. (nmb) (Entered: 05/13/2016)

Entry #4 • 2016-05-13
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Santen Pharmaceutical Co., Ltd.. (nmb) (Entered: 05/13/2016)

Entry #5 • 2016-05-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc